Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Esperion Therapeutics Inc. (ESPR)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Partner Fund Management

Christopher Medlock James

1,627,079 $65,327 -14% 1.44%
2. 2,476,500 $99,431 -1% 1.25%
3.
Bailard Inc

Thomas Bailard

59,500 $2,389 +562% 0.14%
4. 217,100 $8,717 0.03%
5.
Millennium Management

Israel Englander

248,173 $9,964 +201% 0.01%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$40.00 5,000 Officer, Director 61,163 2019-03-29 Filing
$43.48 5,000 Officer, Director 56,163 2019-03-20 Filing
$49.89 50,000 Large Shareholder 3,522,964 2019-03-14 Filing
$48.73 5,000 Officer, Director 51,163 2019-03-14 Filing
$41.29 80,000 Large Shareholder 3,472,964 2019-01-04 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$43.62 1,500 Officer 11,092 2019-04-03 Filing
$42.71 6,500 Officer 12,592 2019-04-03 Filing
$45.25 1,700 Director 0 2019-03-19 Filing
$44.66 13,629 Director 1,700 2019-03-19 Filing
$50.06 25,000 Director 548,726 2019-03-12 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 2,679,835 $107,595 20.17%
2. 975,000 $39,146 4.52%
3. 441,649 $17,732 3.89%
4. 3,522,964 $141,447 3.55%
5. 52,826 $2,121 1.12%
News See All